Two Top Stories of Wall Street: Exact Sciences Corporation (NASDAQ:EXAS), Callidus Software Inc. (NASDAQ:CALD)

Exact Sciences Corporation (NASDAQ:EXAS)

The shares of Exact Sciences Corporation (NASDAQ:EXAS) started off the last trading session with the price of $52.4 while closing the day with the price of $52.57. The shares of Exact Sciences Corporation (NASDAQ:EXAS) Rise 0.92% with the Gain of 0.17 points.

The shares of Exact Sciences Corporation (NASDAQ:EXAS) traded with the day volume of 2.01 Million shares whereas its average trading volume is 2.8 Million.

While analyzing the past performance of the stock we can see that the shares of Exact Sciences Corporation (NASDAQ:EXAS) Gain 0.81% in the last week while rising 7.11% in the last month. Past quarter performance shows the green light with 1.33%. The semi-annual and annual performance shows 26.22% and 157.19% respectively.

Some critical values of the shares of Exact Sciences Corporation (NASDAQ:EXAS) to be discussed here are: the beta which shows the value at 0.79 while Average True Range of Exact Sciences Corporation (NASDAQ:EXAS) demonstrate the value at 2.16. The weekly and monthly volatility of the shares of Exact Sciences Corporation (NASDAQ:EXAS) are indicated at 2.92% and 4.46%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 64.07.

While studying the financial position of the shares of Exact Sciences Corporation (NASDAQ:EXAS), we can see that the Market capitalization of the company is at 6.24 Billion. The shares outstanding for the company is 118.64 Million and the shares float stands at 117.13 Million. The income of the company stand at -239300000 while the sales stand at 266 Million.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -2.04, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 23.45, the Return on Asset ROA stood at -0.216 and the Return on Equity ROE depicted at -0.241 while Return on Investment ROI is at -0.463.


Callidus Software Inc. (NASDAQ:CALD)

Callidus Software Inc. (NASDAQ:CALD) started its previous trading session at $35.95 and closed at $35.92 showing a Fell of -0.07 Percent.

The Company traded with an average Volume of 1.48 Million whereas, its Day Volume stood at 2.01 Million.

Looking at the performance of the stock, Callidus Software Inc. (NASDAQ:CALD) Loss -0.07% in the last week in its shares price and 0.49% in the last month. Quarterly performance shows a green of 25.61 Percent while Semi-Annual and Annual performances shows a 41.72 and 71.48 percent respectively.

Beta for Callidus Software Inc. (NASDAQ:CALD) stands at 1.15 while the ATR (average true range) is at 0.09. The Stock’s Weekly and Monthly Volatility is 0.15% and 0.23% respectively showing a RSI value of 81.14.

While studying the financial position of the shares of Callidus Software Inc. (NASDAQ:CALD), we can see that the Market capitalization of the company is at 2.39 Billion. The shares outstanding for the company is 66.51 Million and the shares float stands at 65.59 Million.

The Company generated an income of -21800000 and the sales of 253.1 Million in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-0.34 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 9.44 respectively.

The Return on Assets stands at -0.05, ROE shows a value of -0.085 and ROI for Callidus Software Inc. (NASDAQ:CALD) is -0.093 as of Trailing Twelve Months period.

The following two tabs change content below.

Eldred Matthew

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Comment